B. Riley Financial Cuts Lam Research (NASDAQ:LRCX) Price Target to $350.00

Lam Research (NASDAQ:LRCXGet Free Report) had its price target lowered by equities researchers at B. Riley Financial from $385.00 to $350.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the semiconductor company’s stock. B. Riley Financial’s price objective would suggest a potential upside of 17.51% from the stock’s previous close.

A number of other analysts have also recently issued reports on the company. Weiss Ratings upgraded Lam Research from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, July 23rd. Evercore reissued an “outperform” rating and issued a $355.00 price objective on shares of Lam Research in a report on Monday, July 20th. UBS Group reissued a “buy” rating and set a $375.00 target price (up from $310.00) on shares of Lam Research in a report on Tuesday, June 9th. TD Cowen reaffirmed a “buy” rating and set a $400.00 target price (up from $340.00) on shares of Lam Research in a report on Thursday, July 9th. Finally, Royal Bank Of Canada boosted their target price on shares of Lam Research from $290.00 to $310.00 and gave the stock an “outperform” rating in a report on Thursday, April 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $359.71.

Get Our Latest Report on Lam Research

Lam Research Stock Performance

NASDAQ:LRCX traded up $45.51 during trading hours on Thursday, reaching $297.86. 11,473,157 shares of the company’s stock were exchanged, compared to its average volume of 11,358,980. Lam Research has a 1-year low of $90.93 and a 1-year high of $438.50. The company has a 50-day moving average of $341.14 and a 200 day moving average of $275.79. The company has a quick ratio of 1.77, a current ratio of 2.54 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $372.49 billion, a price-to-earnings ratio of 56.43, a P/E/G ratio of 1.60 and a beta of 1.80.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to analysts’ expectations of $6.66 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The company’s quarterly revenue was up 30.0% compared to the same quarter last year. During the same period last year, the firm earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Research analysts anticipate that Lam Research will post 5.68 EPS for the current year.

Insider Buying and Selling

In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of the firm’s stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director directly owned 87,142 shares of the company’s stock, valued at $29,192,570. This trade represents a 17.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of Lam Research stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the sale, the director owned 199,205 shares of the company’s stock, valued at approximately $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 98,611 shares of company stock worth $32,250,190. Corporate insiders own 0.31% of the company’s stock.

Institutional Trading of Lam Research

A number of institutional investors have recently added to or reduced their stakes in LRCX. State Street Corp raised its holdings in shares of Lam Research by 0.4% during the 3rd quarter. State Street Corp now owns 59,817,352 shares of the semiconductor company’s stock valued at $8,024,684,000 after purchasing an additional 265,805 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Lam Research by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 33,747,368 shares of the semiconductor company’s stock worth $5,764,117,000 after purchasing an additional 126,613 shares in the last quarter. Invesco Ltd. increased its position in Lam Research by 7.7% during the fourth quarter. Invesco Ltd. now owns 22,821,354 shares of the semiconductor company’s stock worth $3,906,559,000 after buying an additional 1,638,406 shares during the last quarter. Norges Bank acquired a new position in Lam Research during the fourth quarter worth $3,645,427,000. Finally, Price T Rowe Associates Inc. MD raised its holdings in Lam Research by 352.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after buying an additional 10,666,540 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research reported record quarterly revenue of $6.72 billion, up 30% year over year, while adjusted earnings of $1.82 per share exceeded the $1.69 consensus estimate. Strong NAND demand and broader AI-related chip production supported the results. Reuters article
  • Positive Sentiment: The company issued first-quarter fiscal 2027 guidance for revenue of $7.7 billion to $8.5 billion and EPS of $2.00 to $2.30, well above analyst estimates of approximately $7.0 billion and $1.81, respectively. The forecast implies continued momentum from AI-driven semiconductor spending. Lam Research financial results
  • Positive Sentiment: Management highlighted expanding opportunities across memory, advanced packaging and wafer-fabrication equipment as chipmakers increase capacity for AI applications. The upbeat earnings call reinforced expectations for strong semiconductor capital spending in fiscal 2027. Zacks earnings call highlights
  • Positive Sentiment: Needham reaffirmed its Buy rating and assigned a $390 price target. Erste Group also modestly raised its fiscal 2027 EPS estimate to $8.05 from $7.98, indicating improving earnings expectations.
  • Neutral Sentiment: Broader market sentiment was supported by softer inflation data and strong technology-sector earnings, although investors continued to assess Federal Reserve policy and macroeconomic conditions.
  • Negative Sentiment: Concerns remain about potential Chinese lithography advances, regional demand and geopolitical risks, which could affect China-related equipment sales and semiconductor-sector valuations. LRCX’s elevated valuation also leaves the stock sensitive to any slowdown in AI or chip-equipment spending.

About Lam Research

(Get Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

See Also

Analyst Recommendations for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.